Hong Kong stock Abnormal movement | Keji Pharmaceuticals -B (02171.HK) rose more than 3% after earnings, with a net loss of 75.48 million yuan in the first half, a year-on-year decrease of 78.53%.

According to the Wisdom Financial News App, Keji Pharmaceuticals - B (02171.HK) rose more than 3% after its performance announcement. As of the time of publication, it rose 3.68% to HK$21.96, with a trading volume of HK$16.4076 million.